PUBLISHER: The Business Research Company | PRODUCT CODE: 1951633
PUBLISHER: The Business Research Company | PRODUCT CODE: 1951633
Cold remedies are treatments designed to ease symptoms of the common cold, including congestion, cough, and sore throat. They encompass medications, natural therapies, and supportive care to improve comfort and aid recovery. These remedies assist in managing symptoms but do not eliminate the viral infection.
The primary drug categories for cold treatment include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines are drugs that inhibit histamine receptors to alleviate allergy symptoms, including sneezing, itching, and nasal congestion. They are available in various forms such as oral syrups, tablets and pills, nasal drops, lozenges, and others, and are distributed through multiple channels, including hospital pharmacies, retail pharmacies, drug stores, supermarkets and hypermarkets, as well as e-commerce and online pharmacies.
Tariffs have affected the cold remedies market by increasing the cost of imported active ingredients, herbal extracts, and packaging materials used in symptomatic treatments. These impacts have been most pronounced in combination remedy and herbal product segments, particularly in north america and europe where ingredient sourcing is globally diversified. Asia-pacific manufacturers have faced supply disruptions due to import dependencies. However, tariffs have encouraged domestic production of OTC remedies and local sourcing of natural ingredients.
The cold remedies market research report is one of a series of new reports from The Business Research Company that provides cold remedies market statistics, including cold remedies industry global market size, regional shares, competitors with a cold remedies market share, detailed cold remedies market segments, market trends and opportunities, and any further data you may need to thrive in the cold remedies industry. This cold remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cold remedies market size has grown strongly in recent years. It will grow from $9.82 billion in 2025 to $10.4 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to high prevalence of common cold infections, widespread availability of OTC remedies, traditional use of home treatments, strong retail pharmacy penetration, seasonal demand patterns.
The cold remedies market size is expected to see strong growth in the next few years. It will grow to $13.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to growth in self-medication practices, increasing urban population density, rising pollution-related respiratory issues, expansion of e-commerce pharmacies, demand for fast symptom relief. Major trends in the forecast period include rising demand for natural and herbal remedies, growth in multi-symptom relief products, increased preference for OTC cold treatments, expansion of home-based symptom management, growing consumer awareness of self-care options.
The increasing incidence of respiratory infections is expected to drive the growth of the cold remedies market in the coming years. Respiratory infections are illnesses that affect the respiratory system, including the sinuses, throat, airways, and lungs, and are caused by viruses, bacteria, or other pathogens. These infections are on the rise mainly due to weakened immunity resulting from reduced exposure to viruses during pandemic-related lockdowns and social distancing measures. Cold remedies assist in managing respiratory infections by easing symptoms such as congestion, cough, and sore throat, offering relief while the immune system combats the underlying infection. For example, in March 2023, according to the Office for National Statistics, a UK-based government agency, COVID-19 infections in England increased, with approximately 2.66% of the population testing positive (1 in 40 people), and hospital admissions rose to 10.62 per 100,000 individuals. Consequently, the rising incidence of respiratory infections is fueling the growth of the cold remedies market.
Major companies in the cold remedies market are concentrating on creating innovative products, such as clean cough and cold medicines, to address the rising demand for safer, chemical-free options while improving product efficacy and consumer confidence. Clean cough and cold medicines are formulations free from artificial dyes, sweeteners, preservatives, and common allergens, relying on natural or organic ingredients for safer symptom management. For example, in September 2023, Genexa Inc., a US-based healthcare firm, introduced new clean cough and cold medicines for children, including Kids' Multi-Symptom Cold And Flu and Kids' Daytime + Nighttime Cough Relief Value Pack. These products exclude artificial dyes, sweeteners, parabens, and common allergens, using organic agave syrup as a natural substitute for artificial fillers. They deliver effective relief with the same active ingredients as conventional brands but in a clean, non-toxic formulation.
In February 2024, Cipla Limited, an India-based pharmaceutical company, acquired Actor Pharma for $48.6 million. Through this acquisition, Cipla intends to strengthen its over-the-counter (OTC) portfolio by broadening its range of consumer healthcare products, increasing its market presence, and reinforcing its position in the self-care and wellness segment. Actor Pharma (Pty) Limited is a South Africa-based company focused on manufacturing expectorants.
Major companies operating in the cold remedies market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Haleon plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Prestige Brands Holdings Inc., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Centurion Remedies Private Limited, Himalaya Wellness Company, Genexa Inc., Fibovil Pharmaceuticals Pvt. Ltd.
North America was the largest region in the cold remedies market in 2025. The regions covered in the cold remedies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cold remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cold remedies market consists of sales of inhalers, topical rubs, throat sprays, homeopathic remedies, and vitamin supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cold Remedies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cold remedies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cold remedies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cold remedies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.